摘要:
A method for preparation of a hydrogen-storage based electrode comprises treating a powder comprising at least one metal hydride with a first solution. The first solution comprises a first alkaline base and a first reducing agent. The method further comprises fabricating the electrode using the powder and treating the electrode with a second solution comprising a second alkaline base and a second reducing agent.
摘要:
An electrode assembly for use in a galvanic cell is provided. The galvanic cell may include a first electrode, a gel polymer adhesive electrolyte in contact with the first electrode, a polymer tri-phase electrolyte layer, a separator coupled between the gel polymer adhesive electrolyte and the polymer tri-phase electrolyte layer, and a second electrode in contact with the polymer tri-phase electrolyte. A method of making and using an electrode assembly for use in a galvanic cell is provided.
摘要:
A method for preparation of a hydrogen-storage based electrode comprises treating a powder comprising at least one metal hydride with a first solution. The first solution comprises a first alkaline base and a first reducing agent. The method further comprises fabricating the electrode using the powder and treating the electrode with a second solution comprising a second alkaline base and a second reducing agent.
摘要:
The present invention provides for a slow-release inhibitor that is applied to a metal surface, such as by way of a paint or primer coating, for corrosion control of the metal. An exemplary embodiment of the slow-release corrosion inhibitor includes a water-soluble particle, or pigment, and an organic polymeric film that encapsulates the particle. This water-soluble particle may be either organic or inorganic and, preferably, is non-carcinogenic and non-toxic. An additional water-soluble particle having an encapsulating, organic polymeric film further may be provided along with a water-soluble, organic compound to form the corrosion inhibitor. The polymeric film(s) are of a desired hydrophobicity and permeability to permit, upon interaction of the particle(s) with water, controlled diffusion of particle ions therethrough.
摘要:
In one aspect, a lighting fixture may include a light cover, a base and a power cord. In one embodiment, the light cover is hollow to receive a light bulb and made by crystal salt that can be used to emit negative ions to enhance the user's health. In another embodiment, a connecting plate is secured at a bottom portion of the light cover, and the connecting cover has a plurality of screw holes. The base has a circular operating plate that has a plurality of heat dissipating holes surrounding the operating plate to dissipate the heat generate from the light bulb. The operating plate also has a plurality of screw holes corresponding to the screw holes of the connecting plate, so when the screw holes on the operating plate are aligned with the screw holes on the connecting plate, the screws can be inserted into these screw holes to secure the light cover on the base.
摘要:
The present invention provides a GIP analog, which is derived from GIP (1-29, SEQ ID NO: 1), has both GLP-1 agonist activity and GIPR stimulation activity, and comprises an amino acid sequence represented by the following formula I: Tyr-A2-A3-Gly-Thr-Phe-A7-Ser-Asp-Tyr-Ser-A12-A13-A14-A15-Lys-A17-A18-A19-A20-A21-A22-A23-A24-Trp-Leu- A27-A28-A29-Y. The present invention also provides a pharmaceutical composition comprising the GIP analog and use thereof.
摘要翻译:本发明提供衍生自GIP(1-29,SEQ ID NO:1)的GIP类似物具有GLP-1激动剂活性和GIPR刺激活性,并且包含由下式I表示的氨基酸序列: Tyr-A2-A3-Gly-Thr-Phe-A7-Ser-Asp-Tyr-Ser-A12-A13-A14-A15-Lys-A17-A18-A19-A20-A21-A22-A23-A24-Trp- Leu- A27-A28-A29-Y。 本发明还提供了包含GIP类似物及其用途的药物组合物。
摘要:
The present invention provides a GIP analog, which is derived from GIP (1-29, SEQ ID NO: 1), has both GLP-1 agonist activity and GIPR stimulation activity, and comprises an amino acid sequence represented by the following formula I: Tyr-A2-A3-Gly-Thr-Phe-A7-Ser-Asp-Tyr-Ser-A12-A13-A14-A15-Lys-A17-A18-A19-A20-A21-A22-A23-A24-Trp-Leu-A27-A28-A29-Y. The present invention also provides a pharmaceutical composition comprising the GIP analog and use thereof.
摘要翻译:本发明提供衍生自GIP(1-29,SEQ ID NO:1)的GIP类似物具有GLP-1激动剂活性和GIPR刺激活性,并且包含由下式I表示的氨基酸序列: Tyr-A2-A3-Gly-Thr-Phe-A7-Ser-Asp-Tyr-Ser-A12-A13-A14-A15-Lys-A17-A18-A19-A20-A21-A22-A23-A24-Trp- Leu-A27-A28-A29-Y。 本发明还提供了包含GIP类似物及其用途的药物组合物。